By directly targeting anti-apoptotic BCL-2 proteins, G3139 could sensitize virus-infected T cells to apoptosis, highlighting the therapeutic importance of modulating BCL-2 in HTLV infection, where survival of transformed T cells underpins disease progression and treatment resistance. The gene discussed is BCL2; the disease is deltaretrovirus infections.